Impact of community treatment with ivermectin for the control of scabies on the prevalence of antibodies to Strongyloides stercoralis in children.

    Thumbnail
    Download
    Citations
    Altmetric
    Author
    Marks, M; Gwyn, S; Toloka, H; Kositz, C; Asugeni, J; Asugeni, R; Diau, J; Kaldor, JM; Romani, L; Redman-MacLaren, M; ...
    Date
    2020-05-18
    Source Title
    Clinical Infectious Diseases
    Publisher
    Oxford University Press (OUP)
    University of Melbourne Author/s
    Steer, Andrew; Marks, Michael
    Affiliation
    Paediatrics (RCH)
    Metadata
    Show full item record
    Document Type
    Journal Article
    Citations
    Marks, M., Gwyn, S., Toloka, H., Kositz, C., Asugeni, J., Asugeni, R., Diau, J., Kaldor, J. M., Romani, L., Redman-MacLaren, M., MacLaren, D., Solomon, A. W., Mabey, D. C. W., Steer, A. C. & Martin, D. (2020). Impact of community treatment with ivermectin for the control of scabies on the prevalence of antibodies to Strongyloides stercoralis in children.. Clin Infect Dis, https://doi.org/10.1093/cid/ciaa584.
    Access Status
    Open Access
    URI
    http://hdl.handle.net/11343/252405
    DOI
    10.1093/cid/ciaa584
    Abstract
    Prevalence of antibodies to Strongyloides stercoralis was measured in 0-12-year-olds using a bead-based immunoassay before and after ivermectin mass drug administration (MDA) for scabies in the Solomon Islands. Seroprevalence was 9.3% before and 5.1% after MDA (p = 0.019), demonstrating collateral benefits of ivermectin MDA in this setting.

    Export Reference in RIS Format     

    Collections